Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience.
Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience. We translate novel scientific insights into new medicines. That’s a drastic challenge. Our work is complex, risky, labor-intensive, persistent and expensive.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 12, 2021 | Grant | $2.70M | 1 | National Institutes of Health | — | Detail |
Apr 23, 2020 | Grant | $2.50M | 1 | National Institutes of Health | — | Detail |
Sep 21, 2015 | Grant | $1.70M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |